Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

159604 ARTíCULOS , VIENDO DEL 5446 AL 5460

PUBMED

Cholinesterase-inhibitor Associated Mania: A Case Report and Literature Review

Jalal H, Ganesh A, Lau R, Lysack J, Ismail Z.

Can J Neurol Sci. 2014 Mar;41(2):278-80. doi: 10.1017/s0317167100016735.

0

0

0

PUBMED

A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease

Karran E, Hardy J.

Ann Neurol. 2014 Aug;76(2):185-205. doi: 10.1002/ana.24188. Epub 2014 Jul 2.

0

0

0

PUBMED

Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial)

Yu F, Bronas UG, Konety S, Nelson NW, Dysken M, Jack C Jr, Wyman JF, Vock D, Smith G.

Trials. 2014 Oct 11;15:394. doi: 10.1186/1745-6215-15-394.

0

0

0

PUBMED

9th Key symposium introduction: updating Alzheimer's disease diagnosis implications for prevention and treatment

Kivipelto M, Mangialasche F, Solomon A, Johansson G, Lannfelt L, Fratiglioni L, Winblad B.

J Intern Med. 2014 Mar;275(3):202-3. doi: 10.1111/joim.12193.

0

0

0

PUBMED

Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?

Fischer A.

Neuropharmacology. 2014 May;80:95-102. doi: 10.1016/j.neuropharm.2014.01.038. Epub 2014 Jan 31.

0

0

0

PUBMED

Antiamyloid therapy for Alzheimer's disease--are we on the right road?

Karran E, Hardy J.

N Engl J Med. 2014 Jan 23;370(4):377-8. doi: 10.1056/NEJMe1313943.

0

0

0

PUBMED

Brain games to slow cognitive decline in Alzheimer's disease

Anderson K, Grossberg GT.

J Am Med Dir Assoc. 2014 Aug;15(8):536-7. doi: 10.1016/j.jamda.2014.04.014. Epub 2014 Jun 7.

0

0

0

PUBMED

Rethinking dementia

Dennison R.

Br J Community Nurs. 2014 Jan;19(1):5. doi: 10.12968/bjcn.2014.19.1.5.

0

0

0

PUBMED

Sustained 4-year cognitive and functional response in early Alzheimer's disease with pioglitazone

Read S, Wu P, Biscow M.

J Am Geriatr Soc. 2014 Mar;62(3):584-6. doi: 10.1111/jgs.12722.

0

0

0

PUBMED

ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's disease

Romero A, Egea J, González-Muñoz GC, Martín de Saavedra MD, del Barrio L, Rodríguez-Franco MI, Conde S, López MG, Villarroya M, de los Ríos C.

ACS Chem Neurosci. 2014 Sep 17;5(9):770-5. doi: 10.1021/cn500131t. Epub 2014 Jul 15.

0

0

0

PUBMED

Whatever happened to new treatments for Alzheimer's disease?

Devanand DP.

J Clin Psychiatry. 2014 Jul;75(7):775-6. doi: 10.4088/JCP.14ac09246.

0

0

0

PUBMED

Immunotherapy for Alzheimer's disease

Wisniewski T, Goñi F.

Biochem Pharmacol. 2014 Apr 15;88(4):499-507. doi: 10.1016/j.bcp.2013.12.020. Epub 2014 Jan 9.

0

0

0

PUBMED

Anesthetics and its impact on the brain and Alzheimer's disease

Mandal PK, Ritchie K, Fodale V.

J Alzheimers Dis. 2014;39(2):223-5. doi: 10.3233/JAD-131487.

0

0

0

PUBMED

Alzheimer's disease and epigenetic diet

Sezgin Z, Dincer Y.

Neurochem Int. 2014 Dec;78:105-16. doi: 10.1016/j.neuint.2014.09.012. Epub 2014 Oct 5.

0

0

0

PUBMED

Alzheimer's disease and nursing homes

Gaugler JE, Yu F, Davila HW, Shippee T.

Health Aff (Millwood). 2014 Apr;33(4):650-7. doi: 10.1377/hlthaff.2013.1268.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy